Zacks Reiterates Neutral Rating for Eli Lilly and

Home › Zacks Reiterates Neutral Rating for Eli Lilly and

's stock had its "neutral" rating reissued by Zacks in a research report issued on Tuesday. They currently have a $69.00 target price on the stock.

05.10	Hurricane Kirk Graphics
05.10	Hurricane Kirk Forecast Discussion Number 24
05.10	Hurricane Kirk Wind Speed Probabilities Number 24
05.10	Hurricane Kirk Forecast Advisory Number 24
05.10	Hurricane Kirk Public Advisory Number 24
05.10	Summary for Hurricane Kirk (AT2/AL122024)
05.10	Hurricane Leslie Graphics
05.10	Hurricane Leslie Forecast Discussion Number 12
More »

je.st